INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 290 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,231 | +0.2% | 5,015 | +21.8% | 0.06% | -39.4% |
| Q2 2023 | $260,688 | -73.3% | 4,117 | -80.4% | 0.10% | -71.2% |
| Q3 2022 | $978,000 | -45.5% | 21,021 | -33.1% | 0.34% | -56.1% |
| Q2 2022 | $1,794,000 | -14.4% | 31,425 | -8.3% | 0.78% | -20.0% |
| Q1 2022 | $2,096,000 | +45.4% | 34,260 | +24.3% | 0.98% | +305.0% |
| Q4 2021 | $1,442,000 | -51.8% | 27,553 | -76.4% | 0.24% | +24.1% |
| Q2 2020 | $2,993,000 | +28.7% | 116,579 | -22.9% | 0.20% | -4.4% |
| Q1 2020 | $2,325,000 | – | 151,239 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |